Clinical Trials · NCT03085966
Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- Shanghai AbelZeta Ltd.
- Enrollment
- 30
- Start date
- Feb 2017
- Locations
- 1 site, China
- Primary endpoint
- AE and SAE